Table 2.
Compounds | Function |
Target germ layer and cell types |
Ref. | ||
Ectoderm: Neural stem/ progenitor cell, neuron | Mesoderm: Cardiomyocyte | Endoderm/ extraembryonic endoderm: Endoderm progenitor cell, XENs | |||
A83-01 | TGF-βRI (ALK4/5/7) inhibitor | + | + | [42,43,51,53] | |
AM580 | RAR agonist | + | [25,54] | ||
AS8351 | KDM5B inhibitor | + | [53] | ||
Bay K 8644 | Ca2+ channel activator | + | [51] | ||
BIX01294 | Histone methyltransferase inhibitor | + | + | [42,53] | |
CHIR99021 | GSK3 inhibitor | + | + | + | [25,41-46,50,51,53-55,78] |
DMH1 | BMP inhibitor | + | [46] | ||
EPZ004777 | DOT1L inhibitor | + | [25,54] | ||
Forskolin | cAMP activator | + | + | + | [25,44-46,50,51,54,55,78] |
GO6983 | PKC inhibitor | + | [44] | ||
Hh-Ag1.5 | Smo agonist | + | [43] | ||
I-BET151 | BET bromodomain inhibitor | + | [78] | ||
ISX9 | Neurogenic agent | + | [78] | ||
JNJ10198409 | PDGF-RTK inhibitor | + | [53] | ||
LDN193189 | BMP type I receptor (ALK2/3) inhibitor | + | [43,45] | ||
OAC2 | Oct4 activator | + | [53] | ||
Parnate (Tranylcypromine) | LSD1/MAO inhibitor | + | + | + | [25,43,50,54] |
PD0325901 | MEK inhibitor | + | [42,45] | ||
RepSox (616452) | TGF-βRI (ALK5) inhibitor | + | + | + | [25,41,44,46,50,54,55] |
RG108 | DNA methyltransferase inhibitor | + | [42,43] | ||
SB431542 | TGF-βRI (ALK4/7) inhibitor | + | [45,78] | ||
SC1 | ERK1/RasGAP inhibitor | + | [51,53] | ||
SMER28 | Autophagy modulator | + | [43] | ||
SP600125 | JNK inhibitor | + | [44,46] | ||
SU16F | PDGFRβ inhibitor | + | [53] | ||
TTNPB | RAR agonist | + | + | [50,55] | |
VPA | Histone deacetylase inhibitor | + | + | + | [25,41,42,44,46,50,54] |
Y‑27632 | ROCK inhibitor | + | + | + | [44,46,53-55] |
XENs: Extraembryonic endoderm-like cells.